NEOGEN Neogen Chemicals Q1 FY26 results (Apr–Jun 2025) and concall
Neogen Chemicals demonstrated resilience in Q1 FY26, achieving a 4% revenue growth to INR 186.7 crore despite the Dahej plant's unavailability due to a fire incident. The company maintained a steady EBITDA of INR 31.5 crore, supported by sustained volume growth in the base business and initial commercial sales from Neogen Ionics. Strategic initiatives, including the Pakhajan Greenfield facility and the upcoming Morita JV, are progressing, positioning Neogen for future growth in the lithium-ion battery materials segment.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|
| Revenue | 22 | -3 | 5 |
| EBITDA | 38 | 41 | 35 |
| Net profit | 14 | 5 | 14 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
